| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.33 | 0.03 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.4 | 0.03 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 0.03 |